CTM BioTech Company Profile

11:53 EDT 27th May 2015 | BioPortfolio

CTM BioTech offers bio-pharmaceutical companies and research organisations a range of contract services from early stage process development and pre-clinical production through, where required, to later stage project management services.The aim of CTM is to bridge the gap that exists between the clients' in-house, research-phase of development and large-scale GMP production, by working in collaboration with laboratories to enable their products to get to the clinic in a timely, cost efficient manner.
CTM has been designed to meet your organisation's bio-pharmaceutical needs in an innovative way by offering the following range of services:

Location

Babraham Research Campus Babraham Hall
Babraham
Cambridgeshire
CB2 4AT
United Kingdom

Contact

Phone: 44 (0)1223 496 070
Fax: 44 (0)1223 496 061
Email: info@ctmbiotech.co.uk


News Articles [871 Associated News Articles listed on BioPortfolio]

BB Biotech: Biotech-Sektor baut seine Outperformance aus

Küsnacht - Der Nasdaq Biotech Index legte im 4. Quartal weitere 11.2% in USD zu, woraus für das Jahr 2014 eine solide Gesamtrendite von 34.4% in USD resultiert. Das Portfolio von BB Biotech überze....

BB Biotech schlägt Referenzindex - Ausschüttung wird deutlich erhöht

Schaffhausen (awp) - Die Beteiligungsgesellschaft BB Biotech hat einmal mehr vom Aufwärtstrend des Biotech-Sektors profitiert. Im Geschäftsjahr 2014 resultierte für die BB-Biotech-Aktie eine Kursst...

BB BIOTECH AG: BB Biotech: SNB decision does not alter the good fundamentals of the biotech sector

BB BIOTECH AG / BB Biotech: SNB decision does not alter the good fundamentals of the biotech sector . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible f...

BB BIOTECH AG: BB Biotech: The biotech sector extends its outperformance - new technologies an important driver

BB BIOTECH AG / BB Biotech: The biotech sector extends its outperformance - new technologies an important driver . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely ...

BB BIOTECH AG: BB Biotech neu im Stoxx Europe 600

BB BIOTECH AG / BB Biotech neu im Stoxx Europe 600 . Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Source: Globene....

Aktienanalyse BB Biotech: BB Biotech ist eine Beteiligungsgesellschaft, die ...

BB Biotech ist eine Beteiligungsgesellschaft, die vor allem in börsennotierte Biotech Unternehmen investiert, aber auch in kleinere private Firmen aus der Branche. Produkt, Marke und Geschäftsmodel....

Rekorde bei BB Biotech: Wie weit die Aktie noch laufen kann

Biotech-Aktien sind seit Jahren "in" und auch die Aktie von BB Biotech hat einen grandiosen Lauf. Alleine in diesem Jahr hat die Aktie der Schweizer Biotech-Beteiligungsgesellschaft bereits 37 Proz...

Calypso Biotech – auto-immune diseases

Calypso Biotech is a biotech company developing antibody therapies up to clinical proof-of-concept by leveraging its expertise in immunology and drug development. Calypso Biotech’s portfolio consist...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant ...

Companies [844 Associated Companies listed on BioPortfolio]

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

Cella Biotech

Cella Biotech is a company that is specialized in confirming and mapping protein-protein interactions using the yeast two-hybrid system. Companies and institutions can outsource some of their protein-...

More Information about "CTM BioTech" on BioPortfolio

We have published hundreds of CTM BioTech news stories on BioPortfolio along with dozens of CTM BioTech Clinical Trials and PubMed Articles about CTM BioTech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CTM BioTech Companies in our database. You can also find out about relevant CTM BioTech Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record